News | May 13, 2025
Morepen Board proposed dividend after 23 years
Scores highest PAT of Rs. 118 crore in FY25
Scores highest PAT of Rs. 118 crore in FY25
This marks yet another milestone in our series of successful audits over the past year
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
This outcome reflects Innoxel Lifesciences' ongoing commitment to maintaining the highest standards of quality, compliance, and regulatory excellence
Alembic Pharmaceuticals commissions new facility at Pithampur
This approval authorizes the company to export Ibuprofen to the Chinese markets
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
This unit will focus on the manufacturing of health and wellness equipment
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Subscribe To Our Newsletter & Stay Updated
